Literature DB >> 3957108

Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.

P R Harvey, C A Rupar, S Gallinger, C N Petrunka, S M Strasberg.   

Abstract

Human gall bladder mucus glycoprotein was isolated by Sepharose 4B gel filtration followed by caesium chloride density gradient ultracentrifugation from four groups: patients with cholesterol gall stones, patients with pigmented stones, patients with complete obstruction of the cystic duct and patients with no biliary tract abnormalities (controls). Mucus glycoprotein concentrations in cholesterol gall stone bile (203 micrograms/ml +/- 199 SD, n = 17), pigment gall stone bile (110 micrograms/ml +/- 77 SD, n = 6) and control gall bladder bile (96 micrograms/ml +/- 98 SD, n = 11) were not significantly different. While bile from patients with complete obstruction of the cystic duct contained significantly higher concentrations of mucus glycoprotein (6220 micrograms/ml +/- 4130, n = 4). In vitro cholesterol nucleation time was not correlated to gall bladder mucus glycoprotein concentrations. Qualitative analysis of the carbohydrate and amino acid composition showed a basic structure typical of mucus glycoproteins in general. It is unlikely that either quantitative or qualitative differences in mucus glycoproteins are responsible for the rapid in vitro nucleation time characteristic of cholesterol gall stone patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957108      PMCID: PMC1433386          DOI: 10.1136/gut.27.4.374

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Mucous substances and viscosity of normal and pathological human bile.

Authors:  I A Bouchier; S R Cooperband; B M el-Kodsi
Journal:  Gastroenterology       Date:  1965-10       Impact factor: 22.682

2.  Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.

Authors:  D K Podolsky; K J Isselbacher
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

3.  Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis.

Authors:  S P Lee
Journal:  J Pathol       Date:  1981-07       Impact factor: 7.996

4.  Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile.

Authors:  P F Levy; B F Smith; J T LaMont
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

5.  Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones.

Authors:  S P Lee; J T LaMont; M C Carey
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Effect of mucous glycoprotein on nucleation time of human bile.

Authors:  S Gallinger; R D Taylor; P R Harvey; C N Petrunka; S M Strasberg
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

7.  Supersaturated bile from obese patients without gallstones supports cholesterol crystal growth but not nucleation.

Authors:  M J Whiting
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

8.  Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.

Authors:  M J Burnstein; R G Ilson; C N Petrunka; R D Taylor; S M Strasberg
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

9.  Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.

Authors:  S H Gollish; M J Burnstein; R G Ilson; C N Petrunka; S M Strasberg
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

10.  The physicochemical basis of cholesterol gallstone formation in man.

Authors:  W H Admirand; D M Small
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  14 in total

1.  Gallbladder mucin production and calcium carbonate gallstones in children.

Authors:  Craig Sayers; Judy Wyatt; Roger D Soloway; Donald R Taylor; Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2007-01-16       Impact factor: 1.827

2.  Mucin and phospholipids determine viscosity of gallbladder bile in patients with gallstones.

Authors:  D Jüngst; A Niemeyer; I Müller; B Zündt; G Meyer; M Wilhelmi; R del Pozo
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.

Authors:  S Sahlin; J Ahlberg; K Einarsson; R Henriksson; A Danielsson
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

4.  Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.

Authors:  P Janowitz; W Swobodnik; J G Wechsler; A Janowitz; D Saal; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1991-05-03

5.  Increased biliary protein precedes gallstone formation.

Authors:  A J Moser; M Z Abedin; J J Roslyn
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

6.  Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.

Authors:  T Hasegawa; I Makino
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Biosynthesis of a human gall-bladder mucin.

Authors:  L W Klomp; A J de Lely; G J Strous
Journal:  Biochem J       Date:  1994-12-15       Impact factor: 3.857

8.  Histochemical characteristics of glycoproteins in the bile duct system of mice immunized with swine serum.

Authors:  S Itagaki; K Honjo; K Doi; T Mitsuoka
Journal:  Histochemistry       Date:  1988

9.  Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.

Authors:  A Nakano; S Masuzawa; K Ogura; S Fukazawa; K Nakamoto; H Sekido; T Fukushima; S Tsuchiya
Journal:  Gastroenterol Jpn       Date:  1990-02

10.  Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.

Authors:  S Sahlin; A Danielsson; B Angelin; E Reihnér; R Henriksson; K Einarsson
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.